Imricor Medical: Receives CE mark approval for devices
- Imricor Medical Systems (IMR) has received CE mark approval for two of its devices
- This allows the company to market and sell its products to clinical sites in the European Union
- CEO Steve Wedan thrilled their products also will be available in the EU and available to a larger market
- This follows earlier CE mark approval of Imricor’s Advantage-MR EP Recorder/ Stimulation System
- Imricor will also be releasing its quarterly cash flow report from December on January 29 2020
- At market close, Imricor’s share price is up 29 per cent with shares trading for $1.40 each
